Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00439816 · ClinicalTrials.gov registry record · NA

Veteran Preference For Group Visits and Its Effect on Hypertension Outcomes

A NA study of Hypertension and Blood Pressure, sponsored by US Department of Veterans Affairs.

Completed
Registry status
NA
Development phase
160
Enrollment target
1
Study location

NCT00439816: Completed NA study of Hypertension and Blood Pressure, sponsored by US Department of Veterans Affairs.

NCT00439816 is a NA study of Hypertension and Blood Pressure that has completed, run by US Department of Veterans Affairs. The registered enrollment target is 160 participants, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00439816, a NA study of Hypertension and Blood Pressure, has completed, sponsored by US Department of Veterans Affairs.

COMPLETED
Registry status
NA
Development phase
160 participants
Enrollment target
1
Study location

Study Summary

To determine racial/ethnic differences in preference for group visits in veterans with poorly controlled hypertension (State 2 hypertension) and determine the effect of group visits on health outcomes among veterans with poorly controlled hypertension.

Interventions

  • BEHAVIORAL Group Visits

Study Locations (1)

South Carolina

  • Ralph H. Johnson VA Medical Center, Charleston, SC - Charleston

Trial Details

FieldValue
Enrollment Target 160 participants
Start Date 2005-02
Est. Completion 2007-09
Phase NA
US Department of Veterans Affairs

632 total trials

What the finished NCT00439816 record still lists

NCT00439816 is an interventional study that assigns participants to a tested intervention. The registered 160 participants enrollment target is mid-sized for trials with a published cap, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (95% lower).

The record links to 2 conditions, with Hypertension appearing as the primary indexed condition, and to 1 intervention - of which Group Visits is the first listed.

NCT00439816 reports a single indexed study location in South Carolina.

Frequently Asked Questions

What is clinical trial NCT00439816 about?

NCT00439816 is a clinical study titled "Veteran Preference For Group Visits and Its Effect on Hypertension Outcomes". To determine racial/ethnic differences in preference for group visits in veterans with poorly controlled hypertension (State 2 hypertension) and determine the effect of group visits on health outcomes among veterans with poorly controlled hypertension.

What is the current status of trial NCT00439816?

This trial is currently completed. It is a NA study. The enrollment target is 160 participants. The study started on 2005-02. Estimated completion is 2007-09.

What conditions does trial NCT00439816 study?

This clinical trial studies the following conditions: Hypertension, Blood Pressure.

What interventions are being tested in trial NCT00439816?

The interventions under investigation include: Group Visits (BEHAVIORAL).

Who is sponsoring clinical trial NCT00439816?

This trial is sponsored by US Department of Veterans Affairs, which has 632 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00439816 being conducted?

This trial has 1 study location across South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hypertension

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00439816's enrollment target sits among peer trials

160 238th of 470 higher than 228 of 470 other Hypertension trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Hypertension trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00501826 · 160 participants · Phase 2

    Combination Chemotherapy and Nelarabine in Treating Patients With T-cell Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma

  • NCT00992901 · 160 participants · Early Phase 1

    Role of Neural and Hormonal Regulation Factors on Insulin Secretion After Gastric Bypass Surgery

  • NCT01515527 · 160 participants · Phase 2

    Cladribine Plus Low Dose Cytarabine (LDAC) Alternating With Decitabine in Patients With Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndrome (MDS)

  • NCT02193841 · 160 participants · Phase 3

    Simple Bone Cysts in Kids

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00439816, the US trial registry maintained by the National Library of Medicine. NCT00439816 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.